GRI Bio, Inc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GRI Bio, Inc and other ETFs, options, and stocks.

About GRI

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. 

CEO
W. Marc Hertz
CEOW. Marc Hertz
Employees
4
Employees4
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2009
Founded2009
Employees
4
Employees4

GRI Key Statistics

Market cap
3.94M
Market cap3.94M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
175.07K
Average volume175.07K
High today
$1.70
High today$1.70
Low today
$1.53
Low today$1.53
Open price
$1.55
Open price$1.55
Volume
186.97K
Volume186.97K
52 Week high
$43.69
52 Week high$43.69
52 Week low
$1.10
52 Week low$1.10

People also own

Based on the portfolios of people who own GRI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.